Main Article Content
Abstract
Objective – to evaluate the efficacy of ischemic protection of the combined solution based on the HTK (histidine-tryptophan-ketoglutarate) and NEPFOS (not oxygenated perfluororganic solution) in the liver explant conservation.
Materials and methods. We performed a study on 60 rabbits. For histology and morphometry the biopsy of rabbit liver was performed before the conservation and in 8 hours after the conservation in different preservative solutions. Histological and morphometric studies numbered 240.
Results. In 8-hour conservation of liver explants using the combined solution based on HTK and NEPFOS less severe ischemic changes in liver tissue structures have developed compared to monopreservative solutions: standard HTK and control NEPFOS. Therefore, the combined method of conservation reduces the intensity of ischemic injury of the liver explant and thereby increases its vitality, it being the necessary condition for reducing the risk of possible post-transplant complications.
Conclusions. The use of the combined method of conservation can minimize pathological changes in the explant tissues and prevent ischemic liver injury.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Jadlowiec CC, Taner T. Liver transplantation: Current status and challenges. World J Hepatol. 2016; 22(18): 4438-4445
Lee DD, Croome KP, Shalev JA et al. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. Annals of Hepatology. 2016; 15(1): 53-60
Qin1 J, Zhou1 J, Dai1 X et al. Short-term starvation attenuates liver ischemia-reperfusion injury (IRI) by sirt1-autophagy signaling in mice. Am J Transl Res. 2016; 8(8): 3364-3375
Boga S, Munoz-Abraham AS, Rodriguez-Davalos MI et al. Host factors are dominant in the development of post-liver transplant non-alcoholic steatohepatitis. World J Hepatol. 2016; 8(15): 659-664
Chu MJJ, Premkumar R, Hickey AJR et al. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction. World J Gastroenterol. 2016; 22(19): 4673-4684
Folch-Puy E, Panisello A, Oliva J et al. Relevance of endoplasmic reticulum stress cell signaling in liver cold ischemia reperfusion injury. Int. J. Mol. Sci. 2016; (17): 807-819
Nastos C, Kalimeris K, Papoutsidakis N et al. Global сonsequences of liver ischemia/reperfusion injury. Oxidative Medicine and Cellular Longevity. 2014; Article ID 906965: P.13
ÇakırI T, Aslaner IA, TekeliII SÖ et al. Grape seed protects cholestatic rats liver from ischemia/reperfusion injury. Acta Cirúrgica Brasileira. 2016; 31(3): 183-189
Hashimoto N. Protective effect of ischemic preconditioning on hepatic ischemia-reperfusion injury in rats. OA Lib J. 2015; (2): e1306
Jia JJ, Li JH, Jiang L. Liver protection strategies in liver transplantation. Hepatobiliary Pancreat Dis Int. 2015; 14(1): 34-42
Yamanaka K, Houben P, Bruns H et al. A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation. PLoS ONE. 2015; 10(4): e0122214
Pérez JCJ, Ramírez АC, González LT et al. Spironolactone effect in hepatic ischemia/reperfusion injury in wistar rats. Oxidative Medicine and Cellular Longevity. 2016; Article ID 3196431: 9
Peng N, Ai Z, Wang Y et al. Injury mechanism in liver transplantation and its protective measures. JSM Biotechnol Bioeng. 2016; 3(2): 1054-1057
Theodoraki K, Karmaniolou I, Tympa A et al. Beyond preconditioning: postconditioning as an alternative technique in the prevention of liver ischemia-reperfusion injury. Oxidative Medicine and Cellular Longevity. 2016; Article ID 8235921: 21
Schoening W, Ariyakhagorn V, Schubert T et al. Warm HTK donor pretreatment reduces liver injury during static cold storage in experimental rat liver transplantation. Hepatobiliary Pancreat Dis Int. 2015; 14(2): 1-7
Melin C, Miick R, Young NA. Approach to intraoperative consultation for donor liver biopsies. Arch Pathol Lab Med. 2013; 137: 270-274
Shaimardanova C, Fedotovskikh G, Savchuk A. Pathologic criteria to stimate the state of the liver in potential donors. Experimental and Clinical Transplantation. 2015; (3): 33-35.
Naini BV, French SW. Liver Transplant Pathology In: WD Wallace, BV Naini (Eds.), Practical atlas of transplant pathology. Springer International Publishing Switzerland, 2016. P. 111-131.
Petrie A, Sabin K. Reference Medical Statistics. Textbook. 3rd ed., Rev. and ext. Moscow, 2015. 216 p. Russian (Петри А., Сэбин К. Наглядная медицинская статистика. Учеб. пособие. 3-е изд., перераб. и доп. М., 2015. 216 с).
Sukhorukov VP, Ragimov AA, Pushkin SY et al. Perftoran – perfluorocarbon blood substitute with gas transmission function: A guide for physicians. 2nd ed., Rev. and ext. Moscow, 2008. 79 p. Russian (Сухоруков В.П., Рагимов А.А., Пушкин С.Ю. и др. Перфторан – перфторуглеродный кровезаменитель с газотранспортной функцией: пособие для врачей. 2-е изд., перераб. и доп. М., 2008. 79 с.)